Franz Obermayr

Ophthalmology
PANOPTES PHARMA
Austria

Business Expert Ophthalmology
Biography

Franz Obermayr is co-founder and CEO of Panoptes Pharma. Previously he was Head of Clinical Development at Nabriva Therapeutics AG responsible for all clinical programs up to clinical phase 2. His earlier career involved various positions at GPC-Biotech – most recently as Principle Scientist and Director Discovery. During his nine year tenure at GPC-Biotech he led several drug discovery / development programs in Germany and the US. He also played a key role in the commercialization of these programs by managing large collaborations with pharmaceutical companies. Prior to GPC-Biotech he completed his postdoctoral studies at the Max-Planck Institute for Immunobiology in Freiburg. Dr. Franz Obermayr earned his PhD in Biochemistry at the Imperial Cancer Research Fund in London in 1996 

Research Intrest

 opthalmology